Literature DB >> 19222495

Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.

Eui Young Kim1, Won Gu Kim, Won Bae Kim, Tae Yong Kim, Jung Min Kim, Jin-Sook Ryu, Suck Joon Hong, Gyungyub Gong, Young Kee Shong.   

Abstract

OBJECTIVE: The effect of coexistent chronic lymphocytic thyroiditis (CLT) on prognosis in papillary thyroid carcinoma (PTC) patients remains controversial. We evaluated the influence of coexistent CLT on prognostic outcome and the association of coexistent CLT with clinicopathological parameters.
DESIGN: A retrospective study with a median follow-up of 70 months. PATIENTS AND MEASUREMENTS: Patients with PTC who underwent total thyroidectomy followed by (131)I remnant ablation between 1995 and 2003 at Asan Medical Center, Seoul, Korea were enrolled. CLT was diagnosed histopathologically.
RESULTS: Among 1441 patients, 214 (14.9%) had coexistent CLT. A greater female preponderance was noted in the patients with CLT compared with those without CLT (P < 0.01). Mean tumour size in the patients with CLT was smaller than that in patients without CLT (2.0 +/- 1.2 vs. 2.2 +/- 1.4 cm; P = 0.02). One hundred and fifty-one (12.3%) patients without CLT had recurrence, whereas 14 (7.1%) patients with CLT had recurrence during the follow-up period (P = 0.016). In patients with cervical lymph node metastases, those with coexistent CLT showed a significantly lower recurrence rate than those without CLT (P = 0.012). However, this association was lost on multivariate analysis adjusting for other clinicopathological predictors for recurrence.
CONCLUSIONS: In this study, CLT was commonly associated with PTC and was associated with smaller size of the primary tumour at presentation. CLT was also associated with a reduced risk of recurrence during follow-up, although this was not significant after adjustment for other prognostic factors.

Entities:  

Mesh:

Year:  2009        PMID: 19222495     DOI: 10.1111/j.1365-2265.2009.03537.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  66 in total

1.  The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.

Authors:  Ning Qu; Ling Zhang; Dao-Zhe Lin; Qing-Hai Ji; Yong-Xue Zhu; Yu Wang
Journal:  Tumour Biol       Date:  2015-12-21

2.  The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.

Authors:  Young Joo Park; Hwa Young Ahn; Hoon Sung Choi; Kyung Won Kim; Do Joon Park; Bo Youn Cho
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

3.  The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.

Authors:  Yun Zhang; Jiaqi Dai; Tingting Wu; Nailin Yang; Zhiqiang Yin
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-12       Impact factor: 4.553

4.  Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.

Authors:  Cosimo Durante; Sara Tognini; Teresa Montesano; Fabio Orlandi; Massimo Torlontano; Efisio Puxeddu; Marco Attard; Giuseppe Costante; Salvatore Tumino; Domenico Meringolo; Rocco Bruno; Fabiana Trulli; Maria Toteda; Adriano Redler; Giuseppe Ronga; Sebastiano Filetti; Fabio Monzani
Journal:  Thyroid       Date:  2014-05-21       Impact factor: 6.568

Review 5.  The micropapillary/hobnail variant of papillary thyroid carcinoma: A review of series described in the literature compared to a series from one southern Italy pathology institution.

Authors:  Antonio Ieni; Valeria Barresi; Roberta Cardia; Luana Licata; Flavia Di Bari; Salvatore Benvenga; Giovanni Tuccari
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

6.  Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy.

Authors:  Marina S Carvalho; Pedro W Rosario; Gabriela F Mourão; Maria R Calsolari
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

7.  Positive effect of RORγt on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto's thyroiditis.

Authors:  Rong Zeng; Yi Lyu; Guoqiao Zhang; Tao Shou; Kai Wang; Heng Niu; Xinmin Yan
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

8.  Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.

Authors:  Bie-Yu Huang; Chuen Hseuh; Tzu-Chieh Chao; Kun-Ju Lin; Jen-Der Lin
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

9.  Some clinical aspects in chronic autoimmune thyroiditis associated with thyroid differentiated cancer.

Authors:  Ioana Zosin; Ioana Golu; Marioara Cornianu; Mihaela Vlad; Melania Balasa
Journal:  Maedica (Buchar)       Date:  2012-12

10.  Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.

Authors:  Kyung-Eun Kim; Eun-Kyung Kim; Jung Hyun Yoon; Kyung Hwa Han; Hee Jung Moon; Jin Young Kwak
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.